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Abstract
Background: Antibiotics sales without medical prescriptions are increasingly recognized as sources of antimicrobial
misuse that can exacerbate the global burden of antibiotic resistance. We aimed to determine the percentage of
pharmacies who sell antibiotics without medical prescriptions, examining the potential associated risks of such
practice in Riyadh, Saudi Arabia, by simulation of different clinical scenarios.
Methods: A cross sectional study of a quasi-random sample of pharmacies stratified by the five regions of Riyadh.
Each pharmacy was visited once by two investigators who simulated having a relative with a specific clinical illness
(sore throat, acute bronchitis, otitis media, acute sinusitis, diarrhea, and urinary tract infection (UTI) in childbearing
aged women).
Results: A total of 327 pharmacies were visited. Antibiotics were dispensed without a medical prescription in 244
(77.6%) of 327, of which 231 (95%) were dispensed without a patient request. Simulated cases of sore throat and
diarrhea resulted in an antibiotic being dispensed in (90%) of encounters, followed by UTI (75%), acute bronchitis
(73%), otitis media (51%) and acute sinusitis (40%). Metronidazole (89%) and ciprofloxacin (86%) were commonly
given for diarrhea and UTI, respectively, whereas amoxicillin/clavulanate was dispensed (51%) for the other
simulated cases. None of the pharmacists asked about antibiotic allergy history or provided information about drug
interactions. Only 23% asked about pregnancy status when dispensing antibiotics for UTI-simulated cases.
Conclusions: We observed that an antibiotic could be obtained in Riyadh without a medical prescription or an
evidence-based indication with associated potential clinical risks. Strict enforcement and adherence to existing
regulations are warranted.
Background
Antibiotic sales without medical prescriptions have been
observed in many countries [1-5]. This exacerbates the
existing problem of inappropriate use of antibiotics that
leads to an increase in treatment cost, drug adverse
effects, and antibiotic resistance among bacteria [6].
Antibiotic resistance is a global health problem, closely
related to volume of antibiotic consumption [7,8]; there-
fore, restricting antibiotic use and marketing regulations
are among many important strategies to control this
problem [9,10].
However, most initiatives regarding antibiotic misuse
are directed toward optimizing physicians’ prescriptions
[11-16], while other potential sources of antibiotic mis-
use are neglected.
It has been illegal for pharmacists in Saudi Arabia to
dispense an antibiotic without a medical prescription for
more than three decades [17]. However, a previous
study from the Eastern Province of Saudi Arabia
demonstrated a high rate of antibiotic sales without a
prescription for presumed urinary tract infections [18]
due to lack of adherence to these regulations.
Therefore, we sought to determine the percentage of
pharmacies who sell antibiotics without a medical pre-
scription, exploring the potential associated risks of this * Correspondence: itleyjeh@kfmc.med.sa
1Internal Medicine Department, King Fahd Medical City, Aldabab Street,
Riyadh, 11525, Saudi Arabia
Full list of author information is available at the end of the article
Bin Abdulhak et al. BMC Public Health 2011, 11:538
http://www.biomedcentral.com/1471-2458/11/538
© 2011 Bin Abdulhak et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.practice in Riyadh, Saudi Arabia, by simulation of six
different clinical scenarios.
Methods
A cross sectional study of a quasi-random sample of 327
pharmacies was conducted in Riyadh, the capital of
Saudi Arabia with about 5 million habitants, in Novem-
ber 2010. The sample was intended to be representative
of all Riyadh pharmacies. The sample was stratified by
the five regions of Riyadh (Eastern, Western, Northern,
Southern, Central) regardless of the pharmacy’ss i z e ,
deprivation level of the area. A convenience sample of
streets was chosen from each region and a complete
enumeration of all pharmacies in each street was con-
sidered. Each pharmacy was visited once by two investi-
gators (total of 6 male physicians and 2 male medical
students participated) who simulated having a brother/
sister with a predetermined clinical scenario according
to simulated-client method pharmacy surveys [19,20].
The scenarios included sore throat, acute bronchitis, oti-
tis media, acute sinusitis, diarrhea, and urinary tract
infection in a pregnant (childbearing age) women. The
investigators concealed their identity and the study
objective of their visits from the approached pharmacists
who were identified by their licenses and pictures on the
front wall of the pharmacy. The clinical scenarios were
presented as follow; one investigator talked to the phar-
macist while the other observed the discussion and
memorized the responses. Immediately after leaving the
pharmacy, both investigators completed a standardized
data form that included information about the location
of the pharmacy, antibiotics dispensing practice, phar-
macists’ inquiries about associated symptoms (e.g. fever/
shortness of breath/abdominal pain/loin pain), allergy
history, pregnancy status in case of UTI; type of antibio-
tic, if dispensed; and information about drug interac-
tions if this was provided by the pharmacist.
Two sessions of standardization took place in the pre-
sence of all actors. Each group rehearsed simulating all
the clinical scenarios to the senior investigator using the
same complaints (terminology and statements). Rehear-
sal was repeated to ensure reliability of the simulated
scenario. The actors used lay language and refrained
from using any jargon.
Only the following clinical information was presented
to the pharmacist. Any additional information was only
provided if the pharmacist inquired about it. The sore
throat scenario: a healthy young male relative was
described as having difficulties in swallowing with slight
fever of 24 hours duration. Acute bronchitis scenario: an
elderly man relative was described as having sore throat,
cough with sputum production. Additional information
provided upon request was the patient had multiple
comorbid conditions and was using warfarin.
Acute sinusitis scenario: a young male relative was
described as having running nose, facial pain, and head-
ache. Otitis media scenario: a 5-year-old relative child
was described as having ear pain and discharge. Urinary
tract infection scenario: a childbearing female relative
was described as having dysuria and urinary frequency.
Diarrhea scenario: a young male relative was described
with loose bowel motion for one day.
Three levels of demand were used sequentially until
an antibiotic was dispensed or denied [4]: 1) Can I have
something to relieve my symptoms?: 2) Can I have
something stronger? 3) I would like to have an
antibiotic.
Data are presented as percentage of the pharmacists’
responses toward the simulated clinical scenarios.
The study was approved by the Institutional Review
Board at King Fahd Medical City. Deception and incom-
plete disclosure to study subjects (pharmacists) were
considered ethically acceptable because this was a mini-
mal risk study and it could not have been performed
with complete disclosure of investigator entity. Data
were kept anonymous.
Results
Three hundred twenty-seven pharmacies were visited
from all five regions of Riyadh (Eastern, Western,
Northern, Southern, Central).
Antibiotics were dispensed without medical prescrip-
tion from 244 (77.6%) of 327 with different levels of
demand. Simulated cases of sore throat and diarrhea
accounted for the highest percentage of antibiotic sales
without medical prescription (90%) with level one of
demand, followed by UTI (75%), acute bronchitis (73%),
otitis media (51%) and acute sinusitis (40%).
The distribution of the percentage of pharmacies that
dispensed antibiotics without prescription with different
levels of demand for the simulated scenarios is summar-
ized in Table 1.
None of the visited pharmacists asked about history of
drug allergy or provided information regarding potential
drug interactions when dispensing any antibiotics for
any of the simulated clinical scenarios.
Amoxicillin/clavulanate was the most commonly dis-
pensed antibiotic in cases of sore throat, acute bronchi-
tis, acute sinusitis, and otitis media whereas
ciprofloxacin and metronidazole were commonly given
for UTI and diarrhea cases, respectively.
Only 23% of pharmacists who dispensed antibiotics for
UTI simulated cases inquired about pregnancy status.
The majority of pharmacists did not inquire about
associated symptoms, and only few recommended a
medical evaluation. Table 2 summarizes the main inter-
view aspects and the dispensed antibiotics across differ-
ent case scenarios.
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In this representative sample of community pharmacies
in Riyadh, we observed that antibiotic could be easily
obtained without a medical prescription or an evidence-
based indication. These scenarios represent prevalent
diseases that are commonly due to viral infections with
the exception of UTI and otitis media. Despite this fact,
most pharmacists were more likely to provide antibiotics
inappropriately since 97% of diarrhea received antibio-
tics versus 75% of UTI. Moreover, pharmacists dis-
pensed broad spectrum antibiotics without even being
requested by the actors (level one demand).
Table 1 Percentage of Pharmacies Willing to Sell Antibiotics without Medical Prescription According to Strength of
Patient Demand
Level of demand Sore
throat
n=5 8
Acute
sinusitis
n=5 5
Otitis
media
n=5 3
Acute
bronchitis
n=4 4
Diarrhea
n=5 9
UTI
n=5 8
All
n = 327
Level one 53 (90%) 22(40%) 27(51%) 32(73%) 53(90%) 44(75%) 231(70%)
Level two
or three
0(0%) 16(29%) 0(0%) 3(7%) 4(7%) 0(0%) 23(7%)
All level s 53(90%) 38(69%) 27(51%) 35(80%) 57(97%) 44(75%) 254(77.6%)
Evidence based
appropriateness
of antibiotics use
[Reference]
Antibiotics
use confer
relative
benefits [28]
No[29] Antibiotics
use confer
small
benefits[30]
No [31] No[32] Yes[33]
Table 2 Pharmacists’ Inquiries and Recommendations in Response to the Simulated Clinical Scenarios
Simulated clinical
scenario
Recommended medical
evaluation (%)
(95% CI)
Asked about associated
symptoms
(%)
(95% CI)
Asked about
presence of fever
(%)
(95% CI)
Asked about
pregnancy status
(%)
(95% CI)
Dispensed
antibiotic
Sore throat
(n = 58)
5%
(1.1%-14.4%)
40%
(27.0% -53.4%)
9%
(2.9%-19.0%)
NA Amoxicillin/
Clavulanate (60%)
Azithromycin (20%)
Amoxicillin (17%)
Others (3%)
Acute bronchitis
(n = 44)
14%
(5.2%-27.4%)
43%
(28.3%-59.0%)
25%
(13.2%-40.3%)
NA Amoxicillin/
Clavulanate (42%)
Amoxicillin (27%)
Azithromycin (15%)
Others (16%)
UTI
(n = 58)
10%
(3.9%-21.2%)
22%
(12.5%-35.3%)
14%
(6.1%-25.4%)
23%
(12.5%-35.3%)
Ciprofloxacin (86%)
Amoxicillin (7%)
Cefixime (2%)
Clarithromycin (2%)
Others (3%)
Diarrhea
(n = 59)
3%
(0.4%-11.7%)
62%
(49.1%-75.0%)
14%
(6.0%-23.0%)
NA Metronidazole (89%)
Ciprofloxacin (5%)
Cotrimoxazole (2%)
Ofloxacin (2%)
Others (2%)
Acute sinusitis
(n = 55)
2%
(0.0-9.7%)
73%
(59.0%-83.9)
9%
(3.0%-20.0%)
NA Amoxicillin/
Clavulanate (58%)
Azithromycin (26%)
Amoxicillin (8%)
Cefaclor (3%)
Ofloxacillin (3%)
Others (2%)
Otitis media
(n = 53)
47%
(33.3% -61.4%)
19%
(8.3%-29.4%)
2%
(0.0-10.1)
NA Amoxicillin/
Clavulanate (44%)
Amoxicillin (29%)
Cephalexin (15%)
Azithromycin (4%)
Cefaclor (4%)
Cefixime (4%)
NA: Not applicable CI: Confidence interval
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scribed antibiotic for presumed cases of sore throat,
acute sinusitis, acute bronchitis, and otitis media. Addi-
tionally, ciprofloxacin was given frequently for presumed
UTI in a childbearing age women without verifying the
pregnancy status before dispensing this antibiotic which
is FDA class C agent in pregnancy.
Moreover, none of the interviewed pharmacists asked
about allergy history or provided information about
potential drug interactions which may lead to a greater
risk.
The high observed rate of antibiotic sales without a
prescription in Riyadh could be explained by several fac-
tors: lack of enforcement of the national regulations,
suboptimal compliance to the code of ethics and profes-
sionalism among community pharmacists, and financial
interests of community pharmacists [17].
In a systematic review by Morgan et al [21] of 35
community surveys from five continents, non-pre-
scription use of antibiotics occurred worldwide and
accounted for 19-100% of antimicrobial use outside
of northern Europe and North America. Similar to
our findings, Morgan et al observed that non-pre-
s c r i p t i o nu s ew a sc o m m o nf o rn o n - b a c t e r i a ld i s e a s e .
I n2o ft h e3 5s u r v e y s ,m o r et h a n8 0 %o fp h a r m a c i s t s
did not inquire about drug allergy [21]. There was a
wide variation between studies results which could be
attributable to variations in the clinical scenarios
[21]. Other factors which may be responsible for the
variations between studies are level of pharmacists
training, and variations in adherence to the existing
regulations.
Obtaining antibiotics without prescription will not
only promote antimicrobials resistance but can also be
associated with significant adverse events including drug
adverse effects, high cost and complications [6].
Antimicrobial resistance is a major concern associated
with this practice. Memish et al [22] has documented an
increase in resistance to penicillin among all strains of
Streptococcus pneumoniae in Saudi Arabia. Our findings
have shown, for example, inappropriate use of amoxicil-
lin/clavulanate that can contribute to the selective pres-
sure and selection of resistance to this class of antibiotic
that is usually held “in reserve”.
Adverse drug reactions represent another major con-
cern. In a meta-analysis of 39 prospective studies from
US hospitals, the overall incidence of serious adverse
drug reactions (ADRs) was 6.7% (95% confidence inter-
val [CI], 5.2%-8.2%) and of fatal ADRs was 0.32% (95%
CI, 0.23%-0.41%) of hospitalized patients [23].
In another analysis of drug-related adverse events
from the National Electronic Injury Surveillance Sys-
tem-Cooperative Adverse Drug Event Surveillance pro-
ject (2004-2006) and outpatient prescriptions from
national sample surveys of ambulatory care practices,
the National Ambulatory Medical Care Survey and the
National Hospital Ambulatory Medical Care Survey
(2004-2005), an estimated 142,505 visits (95% confi-
dence interval [CI], 116,506-168,504 visits) annually
were made to US Emergency Departments (EDs) for
drug-related adverse events attributable to systemic
antibiotics. Antibiotics were implicated in 19.3% of all
ED visits for drug-related adverse events. Most ED vis-
its for antibiotic-associated adverse events were for
allergic reactions (78.7% of visits; 95% CI, 75.3%-82.1%
of visits) [24].
In addition, serious drug interaction is a major sequa-
lea. Amoxicillin/clavulanate, for example, interacts with
warfarin and lead to an increasing bleeding risk. Failure
of pharmacists to ask patients about concomitant medi-
cations poses a significant risk to patients.
Moreover, pregnancy status is a critical situation to
consider when giving any medication to a child bearing
woman. In our simulated case scenario, a pregnant
woman could have been exposed to a Class C medica-
tion(Ciprofloxacin); while the evidence supports avoid-
ing this drug during pregnancy because of the
difficulty in extrapolating animal mutagenicity results
to humans and interpretation of the toxicity is still
controversial[25].
Parasitic infestation is not highly prevalent in Riyadh
[26]. However, metronidazole was dispensed, based on
no supporting evidence to most simulated cases of
diarrhea. Metronidazole can cause serious side effects
such as seizure, encephalopathy, and peripheral neuro-
pathy [27].
Future studies should examine reasons why patients
seek non-prescribed medications directly from pharma-
cists despite the presence of public hospitals and pri-
mary care centers.
Our study findings may not be generalizable to other
countries. Although the actors were medical profes-
sionals, they have not used medical jargon to avoid
introducing bias in favor of antibiotic sale without
prescription.
Conclusion
In a representative sample of community pharmacies in
Riyadh, we observed that antibiotics could be easily
obtained without a medical prescription or an evidence-
based indication. There are major potential sequalae
associated with this practice. There is a need for strict
enforcement and adherence to existing regulations
regarding antibiotics sale. Educating the public about
the worldwide existing problems of antibiotic resistance,
drug adverse effects and unnecessary cost associated
with antibiotic sales without medical prescription is
urgently needed.
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